ATLANTA—Results from the first large study of a vaccine for dengue fever — in 4000 Thai children — show that it is safe to use and effective — raising immunity to three out of the four “serotypes” of this mosquito-borne virus. Although these findings — announced at the American Society of Tropical Medicine and Hygiene annual meeting — show that complete protection — against all four virus types — is still not possible, Professor Jeremy Farrar of Oxford University’s Unit in Ho Chi Minh city told Peter Goodwin that expectations about the vaccine were perhaps too high, and that the results just announced are encouraging, because the risk of dengue is continually rising as more people travel around the world spreading the infection.
You may also like...
Diagnostic Tests Spearhead The Fight Against Malaria 1 Dec, 2010 Malaria Elimination: Research Findings At ASTMH Conference 2 Jan, 2012 Can Road-Side Tranexamic Acid Therapy Reduce Mortality and Blood Transfusions after Trauma? The CRASH Trial. 9 May, 2007 Integrase Inhibitor Raltegravir Doubles Antiviral Response Rate in Treatment Experienced HIV-Infected Patients Compared to Optimised Background Therapy Alone 6 Mar, 2007
- Previous story New drug looks very promising in high risk chronic lymphocytic leukaemia
- Next story Acute promyelocytic leukaemia: arsenic better than chemotherapy to combine with retinoic acid?
- COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014